SecBot SecBot

RS

RELIANCE, INC.
NYSE· Wholesale-Metals Service Centers & of fices· Inc. DE· CIK 0000861884
$421.07 −6.26 (−1.46%)
Nov 16 4:00 PM ET · prev $427.33
Market cap
$22.1B
Large cap
Consensus
Buy
47% Buy or better · 19 analysts
Median target
$435.00
+3% · range $420.00–507.00
1 year
+58.1%
from $266.31 · Nov 17
30 days
+1.3%
from $415.67
52-week range
$265.93–448.08
−6% from high · low Nov 18
Avg volume 20D
344.2K
shares / day
Short interest
1.30M
≈2.5% of shares · +11.6%
Days to cover
3.7
at average volume
Insider net
−$17.0M
0 buyers · 4 sellers · 12 mo
New fund stakes
4
Q2 2026 13F · 0 exits
Filing reports
9
analyzed by SecBot
SecBot read BULLISH 4 reports · 90 days
Balance 0 bearish · 2 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/4

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    4 insiders sold $17.0M.

  • InstitutionsBULLISH

    Q2 2026: 45 added (4 new), 21 trimmed or exited. Largest new: Renaissance Technologies $24.8M, Balyasny Asset Management $19.1M.

  • AnalystsBULLISH

    9 of 19 rate it Buy or better. Median target $435.00 (+3%).

  • Short sellersSTEADY

    Short interest +11.6% to 1.30M shares. 3.7 days to cover, ≈2.5% of shares.

  • TrendUPTREND

    3% above its 50-day average.

Who's buying

13F· Q2 2026
4
new positions
0
exits
$71.1M
in new stakes
FundMoveSharesValue
JPMORGAN CHASE & COADD625,356$235.0M
FMR LLCTRIM301,975$112.8M
GOLDMAN SACHS GROUP INCADD282,315$105.5M
CITADEL ADVISORS LLCDOUBLED275,606$103.0M
Qube Research & Technologies LtdADD249,841$93.3M
Life Cycle Investment Partners LtdADD166,117$62.1M
JANE STREET GROUP, LLCDOUBLED148,082$55.3M
Robeco Institutional Asset Management B.V.DOUBLED139,032$51.9M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

19 analysts
Buy 47% rate it Buy or better
Strong Buy3Buy6Hold9Sell1Strong Sell0
12-month targets · 9 analysts

Price is inside the target range. Median implies +3%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 12, 2026Barclays
UPGRADE
UPGRADEOverweight
Nov 6, 2026Citigroup
MAINTAIN
MAINTAINNeutral
Oct 28, 2026JP Morgan
MAINTAIN
MAINTAINNeutral
Oct 26, 2026Barclays
MAINTAIN
MAINTAINEqual-Weight
Oct 26, 2026Keybanc
MAINTAIN
MAINTAINOverweight
Oct 22, 2026Wells Fargo
MAINTAIN
MAINTAINEqual-Weight

Insider ledger

Form 4
$0
bought · 0 insiders
$17.0M
sold · 4 insiders
DateInsiderTypeValue
Oct 27, 2026
Koch Stephen Paul
Exec. VP, COO
Oct 27, 2026
SELL$1.8M
Oct 27, 2026
Koch Stephen Paul
Exec. VP, COO
Oct 27, 2026
SELL$1.4M
Oct 27, 2026
Koch Stephen Paul
Exec. VP, COO
Oct 27, 2026
SELL$434.0K
Aug 26, 2026
Colonias Karen Winifred
Director
Aug 26, 2026
SELL$601.6K
Jul 31, 2026
Ajemyan Arthur
SVP, CFO
Jul 31, 2026
SELL$902.2K
Jul 28, 2026
Smith William A II
SVP, General Counsel, Corp Sec
Jul 28, 2026
SELL$398.2K
Jul 28, 2026
Smith William A II
SVP, General Counsel, Corp Sec
Jul 28, 2026
SELL$576.5K
May 20, 2026
Baldwin Lisa
Director
May 20, 2026
AWARD469 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
1,297,263
shares short
+11.6%
vs prior settlement
3.7
days to cover
≈2.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Oct 30, 2026 SEC
Five institutional investors, led by Robeco Institutional Asset Management, more than doubled their positions in…
INST-CLUSTER · Impact 4/10
Oct 27, 2026 SEC
Stephen Paul Koch, an officer of Reliance, Inc., filed a Form 144 notice of intent to sell 8,344 shares of common…
144 · Impact 3/10
Oct 27, 2026 Insider
Koch Stephen Paul sold 4,194 shares
Exec. VP, COO @ $430.28 ($1.8M)
Oct 27, 2026 Insider
Koch Stephen Paul sold 3,136 shares
Exec. VP, COO @ $431.22 ($1.4M)
Oct 27, 2026 Insider
Koch Stephen Paul sold 1,004 shares
Exec. VP, COO @ $432.23 ($434.0K)
Oct 21, 2026 SEC
Reliance, Inc. reported Q3 2026 non-GAAP EPS of $8.02, significantly exceeding management's guidance of $6.40-$6.60…
8-K · Impact 7/10
Oct 21, 2026 Earnings result
RS Q3 2026 Earnings: EPS $8.02 (+16.9% vs est)
Jul 15, 2026 Event
Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01
Class II: Lack of Sterility Assurance
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 21, 2026
Earnings result
RS Q3 2026 Earnings: EPS $8.02 (+16.9% vs est)
Sep 24, 2026
Gov. contract
$547M govt contract mod: AMI METALS, INC
Agency: Department of Homeland Security. Mod P00004: MODIFICATION TO EXERCISE OPTION PURSUANT TO FAR 52.217-6 FOR 200,000 TONS OF STEEL AND…
Sep 2, 2026
Press release
Reliance, Inc. Announces Participation at the 2026 Jefferies Global Industrials Conference
PHOENIX, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Reliance, Inc. (NYSE: RS) announced today that Karla Lewis, President and Chief Executive Officer, and…
Jul 22, 2026
Earnings date
RS Q2 2026 Earnings Scheduled, 2026-07-22
Jul 15, 2026
FDA
Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01
Class II: Lack of Sterility Assurance

SecBot reports

9 filings · 1 press release · 4 bullish · 1 bearish · 1 mixed · 3 neutral
All RS filing & press-release reports (10)